• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants

tetano

Editor, Senior Moderator
Sci Rep. 2017 Mar 17;7:44727. doi: 10.1038/srep44727.
[h=1]The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants.[/h] Wong SS[SUP]1[/SUP], Duan S[SUP]2[/SUP], DeBeauchamp J[SUP]1[/SUP], Zanin M[SUP]1[/SUP], Kercher L[SUP]3[/SUP], Sonnberg S[SUP]1[/SUP], Fabrizio T[SUP]1[/SUP], Jeevan T[SUP]1[/SUP], Crumpton JC[SUP]1[/SUP], Oshansky C[SUP]2[/SUP], Sun Y[SUP]4[/SUP], Tang L[SUP]4[/SUP], Thomas P[SUP]2[/SUP], Webby R[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Because of the pathogenicity and low incidence of avian influenza virus infections in humans, the immune correlates of protection for avian influenza vaccines cannot be determined from clinical studies. Here, we used the ferret model to address this for an avian influenza H5N1 vaccine. Using oil-in-water adjuvants, we generated groups of ferrets with undetectable (geometric mean titer [GMT] < 10), low (GMT = 28.3), or high (GMT > 761.1) hemagglutination-inhibition (HAI) titers to the A/Viet Nam/1203/2004 (H5N1) virus. Ferrets were then challenged with the wild-type virus and disease severity and immunologic parameters were studied. The severity of infection and symptom profile were inversely associated with pre-challenge HAI titers in a dose-dependent manner. A vaccinated ferret with no detectable HAI-antibodies but high flu-specific IgG-antibody titers mounted rapid functional antibodies after infection and experienced milder disease compared to other ferrets in the group. Compared to na?ve ferrets, all vaccinated ferrets showed improved cellular immunity in the lungs and peripheral blood. High number of IFNγ[SUP]+[/SUP] CD8- T cells in the airways was associated with early viral clearance. Thus, while neutralizing antibodies are the best correlate of protection, non-neutralizing antibodies can also be protective. This should be taken into consideration in future avian influenza vaccine trials.


PMID: 28303960 DOI: 10.1038/srep44727
 
Back
Top Bottom